Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FBGD7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,456
Award facts
- Contract value 100% obligated
- $27,455.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a contract ceiling value of $27,455.98. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the contract is scheduled for completion by December 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical product deliveries, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The underlying SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medical commodities to customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support has plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, indicating the strategic importance of this pharmaceutical supply capability to federal defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FBGD7?
SPE2DR26FBGD7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FBGD7 worth?
The government has obligated $27,456 on SPE2DR26FBGD7.
Is contract SPE2DR26FBGD7 an order under another contract?
Yes. SPE2DR26FBGD7 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGD7 competed?
The extent of competition for SPE2DR26FBGD7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award